"Drugmaker EMD Serono will reduce the cost of a common fertility medication through a deal struck with the Trump administration, President Donald Trump said Thursday while also unveiling new federal guidance he said will encourage employers to offer fertility coverage. The new guidance will allow companies to offer fertility benefits separate from major medical insurance plans, like they do with dental and vision plans, Trump said."
"The Oval Office announcement offers a first glimpse at how Trump plans to follow up on his executive order earlier this year aiming to reduce the cost of in vitro fertilization, a medical procedure that helps people facing infertility build their families. But it falls far short of his promise as a candidate to make IVF treatment free. It marks the third deal the administration has made with pharmaceutical companies to cut drug prices in recent weeks."
"EMD Serono's Gonal-f is among several drugs frequently used by patients going through IVF treatments - which involve using hormones to trigger ovulation, producing multiple eggs that are retrieved from the ovaries to be fertilized or frozen. The drugs can be expensive, often costing patients thousands of dollars for a single IVF cycle. Many patients trying to get pregnant through IVF go through more than one cycle. Trump said the drug will be available at a discount on TrumpRx, a government website where patients will be able to buy drugs directly from manufacturers."
EMD Serono agreed to reduce the price of a commonly used fertility medication under a deal with the Trump administration, while new federal guidance will allow employers to offer fertility benefits separately from major medical insurance, similar to dental and vision plans. The measures follow a February executive order aimed at making in vitro fertilization more affordable but do not enact a promise to make IVF free. Gonal-f, commonly used to stimulate ovulation for IVF, will be offered at a discount on TrumpRx, and FDA cooperation may speed approval of Pergoveris from Europe.
Read at Fortune
Unable to calculate read time
Collection
[
|
...
]